Vitamin k1 | Vitamin K2 | Placebo | ANOVA | |||||
---|---|---|---|---|---|---|---|---|
Mean ±SD | Range | Mean ±SD | Range | Mean ±SD | Range | F | P-value | |
Baseline PTH (pg/ml) | 618±598.07 | 15–3380 | 690.88±535.81 | 20–2024 | 570 ±457.742 | 49–2357 | 0.52 | 0.596 |
Baseline Ca+ (mg/dl) | 8.845±1.09 | 6.3–11.3 | 8.525±0.793 | 6.6–10.4 | 8.685±0.689 | 7.5–10.4 | 1.341 | 0.266 |
3 months Ca+ (mg/dl) | 8.82±1.227 | 5.3–11.3 | 8.555±0.981 | 4.9–10.3 | 8.768±1.048 | 4.8–11.3 | 0.663 | 0.517 |
Differences | 0.025±0.801 | (− 0.03±0.633) | (− 0.083±0.834) | |||||
P-value | 0.845 | 0.766 | 0.535 | |||||
BaselinePO4 (mg/dl) | 4.3±1.759 | 0.8–10 | 4.543±1.791 | 2.2–10.3 | 4.865±1.649 | 1.8–8.6 | 1.069 | 0.347 |
3 monthsPO4 (mg/dl) | 4.25±1.974 | 1.2–9.6 | 4.263±1.572 | 2.2–8.5 | 4.13±1.399 | 1.5–7.7 | 0.077 | 0.926 |
Differences | 0.05±1.334 | 0.28±1.21 | 0.735±1.355 | |||||
P-value | 0.814 | 0.151 | 0.001* | |||||
BaselineCa2+ and PO4 product | 37.639±15.859 | 9.04–88 | 39.106±17.858 | 17.82–107.12 | 42.101±14.386 | 16.56–76.54 | 0.799 | 0.452 |
3 months Ca2+ and PO4 product | 37.35±19.267 | 11.76–99.84 | 36.817±15.621 | 16.94–73.47 | 36.182±13.359 | 16.95–74.69 | 0.052 | 0.95 |
Differences | 0.289±11.438 | 2.289±10.97 | 5.92±11.105 | |||||
p-value | 0.874 | 0.195 | 0.002* |